推薦產品
材料
(flouropolymer)
(thermoplastic elastomer)
device
polypropylene
silicone (thermoplastic elastomer)
品質等級
agency
according to ISO 11137
meets EN 2.6.14
meets JP 4.01
meets USP 85
無菌
sterile; γ-irradiated (at 25-40 kGy)
參數
-196- 60 °C temp. range (-321- 140 °F)
0.3 bar max. pressure (4.4 psi)
60 mL process volume
容量
100 mL
雜質
<0.25 EU/mL Aqueous extraction (LAL test)
應用
mAb
儲存溫度
2-30°C
尋找類似的產品? 前往 產品比較指南
一般說明
Our Mobius® High Cell Density Cryopreservation (HCDC) Assembly (-196C) is a single-use assembly specially designed to facilitate the freeze and thaw of cryopreserved cells in liquid nitrogen vapor phase (? -196°C). Available in two assembly bag sizes of 100 mL and 250 mL, our Mobius® HCDC Assembly (-196C) enables seed train inoculation with cells at a higher cell density and larger volume compared to the traditional seed train process using vials, which significantly accelerates the cell expansion process. Our Mobius® single-use assembly also provides a closed processing environment preventing contamination while improving process reproducibility.
特異性
Application
應用
包裝
成分
Pinch clamp: Nylon
其他說明
法律資訊
什麼是Emprove® 套裝?
Emprove® 計劃是一個為我們的篩選器和單次用元件、製藥原料和起始材料提供全面徹底記錄的系統。
文章
This page describes the design attributes of the Cellicon® filter assembly for cell retention and how they simplify scale-up of intensified upstream processes.
High cell density cryopreservation (HCDC) is a closed processing alternative to the traditional seed train expansion process. Learn more about the benefits of HCDC.
How the Cellicon® filter and controller enables seamless adoption of a perfused N-1 seed train step into the cell expansion process.
Cellvento 4CHO-X Expansion Medium enhances cell biomass for bioreactor inoculation in cell expansion stages.
相關內容
Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.
Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.
生物製藥開發商需要高效率、高生產力的上游製程,以提供高品質的單株抗體 (mAbs) 及其他類型的重組蛋白質。製程強化可確保未來的製造策略、降低成本並增加設備的彈性。
生物製藥開發商需要高效率、高生產力的上游製程,以提供高品質的單株抗體 (mAbs) 及其他類型的重組蛋白質。製程強化可確保未來的製造策略、降低成本並增加設備的彈性。
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務